This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In a new study published in iScience, Mayo Clinic researchers found that a novel 4D echo imaging method that measures cardiac strain may detect subtle changes in the heart'sdysfunction during acute myocarditis, a deadly heartdisease.
mtaschetta-millane Thu, 07/11/2024 - 10:53 July 11, 2024 — Heart Test Laboratories, Inc. AI-ECG is set to change the detection of heartdisease and this latest patent further bolsters value to HeartSciences and our stakeholders.” GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.
Heart failure with preserved ejection function is a lethal form of heart failure, with few effective treatments. A team has now identified an enzyme, alpha-kinase 2 (ALPK2), that is specifically expressed in the heart and regulates the heartdysfunction that leads to heart failure with preserved ejection function.
An increasing number of preclinical and clinical studies have confirmed a causal relationship between heart and brain diseases. Cardiogenic dementia is a cognitive impairment caused by heartdysfunction and has received increasing research attention.
As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heartdisease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease. About 32% had Type 2 diabetes.
As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heartdisease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease. About 32% had Type 2 diabetes.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content